Literature DB >> 25128973

Distinct phenotypes of cardiac allograft vasculopathy after heart transplantation: a histopathological study.

Manon M H Huibers1, Aryan Vink2, Johannes Kaldeway2, André Huisman2, Kim Timmermans2, Max Leenders3, Marguèrite E I Schipper2, Jaap R Lahpor4, Hans J H Kirkels5, Corinne Klöpping5, Nicolaas de Jonge5, Roel A de Weger2.   

Abstract

INTRODUCTION: Long-term survival after heart transplantation (HTx) is hampered by cardiac allograft vasculopathy (CAV). Better understanding of the pathophysiological mechanisms of CAV might have considerable consequences for therapeutic approaches in the future. The aim of the present study was to investigate the histological phenotypes of CAV in relation with clinical patient characteristics. METHODS AND
RESULTS: Coronary cross-sections from 51 HTx patients were obtained at autopsy. CAV was observed in 42 patients (82%). Three histological CAV phenotypes were identified (H-CAV 1-3). No CAV (H-CAV 0) is as seen in normal coronary arteries; intimal thickening consisting of a layer of longitudinal oriented smooth muscle cells. In H-CAV 1 to 3 a second intimal layer is formed, on top of the longitudinal oriented smooth muscle cell layer, with predominantly mononuclear inflammatory infiltrate in loose connective tissue (H-CAV 1), smooth muscle cells in different orientation (H-CAV 2), or a fibrotic intimal lesion (H-CAV 3). H-CAV type was significantly related with time after transplantation, age at transplantation, the amount of atherosclerotic disease and the occurrence of infection. In addition, morphometric analysis revealed that higher H-CAV types have a relatively larger intimal area, that is compensated for by expansive arterial remodeling of the artery.
CONCLUSION: CAV in an ongoing process that can be classified into three different phenotypes; inflammatory lesions, lesions rich of smooth muscle cells and fibrotic lesions. Our results suggest that these phenotypes are related to time after transplantation, age at transplantation, the amount of atherosclerotic disease and the occurrence of infection.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Arterial remodeling; Cardiac allograft vasculopathy; Heart transplantation; Histology

Mesh:

Substances:

Year:  2014        PMID: 25128973     DOI: 10.1016/j.atherosclerosis.2014.07.016

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  4 in total

Review 1.  Complications of Cardiac Transplantation.

Authors:  Luciano Potena; Andreas Zuckermann; Francesco Barberini; Arezu Aliabadi-Zuckermann
Journal:  Curr Cardiol Rep       Date:  2018-07-10       Impact factor: 2.931

Review 2.  Cardiac allograft vasculopathy: a donor or recipient induced pathology?

Authors:  Patricia van den Hoogen; Manon M H Huibers; Joost P G Sluijter; Roel A de Weger
Journal:  J Cardiovasc Transl Res       Date:  2015-02-05       Impact factor: 4.132

3.  Cardiac allograft vasculopathy in Dutch heart transplant recipients.

Authors:  G Galli; K Caliskan; A H M M Balk; R van Domburg; O Birim; J Salerno-Uriarte; O C Manintveld; A A Constantinescu
Journal:  Neth Heart J       Date:  2016-12       Impact factor: 2.380

4.  TET2 Protects Against Vascular Smooth Muscle Cell Apoptosis and Intimal Thickening in Transplant Vasculopathy.

Authors:  Allison C Ostriker; Yi Xie; Raja Chakraborty; Ashley J Sizer; Yalai Bai; Min Ding; Wen-Liang Song; Anita Huttner; John Hwa; Kathleen A Martin
Journal:  Circulation       Date:  2021-06-11       Impact factor: 39.918

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.